Global Human Vaccine Adjuvants Market by 2030: Growth, Drivers, and Emerging Opportunities The global Human Vaccine Adjuvants Market is poised for significant expansion, driven by increasing immunization needs and rapid advancements in vaccine technologies. According to industry analysis, the market was valued at US$ 1,571.41 million in 2022 and is projected to reach US$ 4,489.23 million by 2030, registering a robust CAGR of 14.0% during 2022–2030. This remarkable growth...
0 condivisioni
12 Views
0 Anteprima